Tag Archives: Jean Jacques Bienaime

The CEO of BioMarin Pharmaceutical (NASDAQ: BMRN) is Buying Shares

Today, the CEO of BioMarin Pharmaceutical (BMRN – Research Report), Jean Jacques Bienaime, bought shares of BMRN for $753. Following Jean Jacques Bienaime’s last BMRN Buy transaction on September 30, 2019, the stock climbed by 12.5%. See today’s analyst top

The CEO of BioMarin Pharmaceutical Inc. is Exercising Options

Today it was reported that the CEO of BioMarin Pharmaceutical Inc. (BMRN – Research Report), Jean Jacques Bienaime, exercised options to buy 1,000 BMRN shares at $21.51 a share, for a total transaction value of $21.51K. See today’s analyst top

The CEO of BioMarin is Exercising Options

Yesterday, the CEO of BioMarin, Jean Jacques Bienaime, exercised options of BioMarin for $32.25K. Over the last month, Jean Jacques Bienaime has reported another 5 Buy trades on BMRN for a total of $1.22M. Based on BioMarin’s latest earnings report

The CEO of BioMarin (NASDAQ: BMRN) is Buying Shares

Yesterday, the CEO of BioMarin (NASDAQ: BMRN), Jean Jacques Bienaime, bought shares of BMRN for $14.39K. This is Bienaime’s first transaction since reporting a Buy transaction on VTL back in September 2017 Based on BioMarin’s latest earnings report for the